These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 39029232

  • 1. Plasma proteomic profiling reveals that SERPINE1 is a potential biomarker associated with coronary artery lesions in Kawasaki disease.
    Wang N, Gao Y, Wang Y, Dai Y, Tang Y, Huang J, Sun L, Qian G, Ma J, Li X, Liu Y, Yang D, Huang X, Wang W, Li W, Zhuo W, Lv H, Liu Z.
    Int Immunopharmacol; 2024 Sep 30; 139():112698. PubMed ID: 39029232
    [Abstract] [Full Text] [Related]

  • 2. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
    J Int Med Res; 2024 May 30; 52(5):3000605241252115. PubMed ID: 38713460
    [Abstract] [Full Text] [Related]

  • 3. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
    Wu Y, Wang S, Zhou Y, Yang Y, Li S, Yin W, Ding Y.
    PLoS One; 2023 May 30; 18(10):e0292653. PubMed ID: 37824465
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
    Eur J Pediatr; 2023 Oct 30; 182(10):4399-4406. PubMed ID: 37480545
    [Abstract] [Full Text] [Related]

  • 5. Association between adropin and coronary artery lesions in children with Kawasaki disease.
    Yang M, Pei Q, Zhang J, Weng H, Jing F, Yi Q.
    Eur J Pediatr; 2021 Jul 30; 180(7):2253-2259. PubMed ID: 33712900
    [Abstract] [Full Text] [Related]

  • 6. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 30; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 7. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
    Pediatr Infect Dis J; 2018 Oct 30; 37(10):976-980. PubMed ID: 29461447
    [Abstract] [Full Text] [Related]

  • 8. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
    [Abstract] [Full Text] [Related]

  • 9. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.
    Ohnishi Y, Yasudo H, Suzuki Y, Furuta T, Matsuguma C, Azuma Y, Miyake A, Okada S, Ichihara K, Ohga S, Hasegawa S.
    Int J Cardiol; 2019 Oct 01; 292():236-240. PubMed ID: 31200965
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of serum soluble TNF receptor II level and soluble TNF receptor II/I ratio as indicators of coronary artery lesion development in Kawasaki disease.
    Shimizu M, Mizuta M, Usami M, Inoue N, Sakakibara Y, Yamada K, Konishi M, Ohta K, Yachie A.
    Cytokine; 2018 Aug 01; 108():168-172. PubMed ID: 29625336
    [Abstract] [Full Text] [Related]

  • 11. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
    Duan Y, Li H, Luo D, Jiang J, Liu B, Li G.
    Int Immunopharmacol; 2023 Sep 01; 122():110600. PubMed ID: 37423157
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar 01; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

  • 13. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.
    Chen YL, Wang JL, Li WQ.
    Eur J Pediatr; 2014 Nov 01; 173(11):1467-71. PubMed ID: 24889335
    [Abstract] [Full Text] [Related]

  • 14. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A, Pal P, Basu S.
    Rheumatol Int; 2019 Oct 01; 39(10):1797-1801. PubMed ID: 31302740
    [Abstract] [Full Text] [Related]

  • 15. Expression of nuclear factor -κBp65 in mononuclear cells in Kawasaki disease and its relation to coronary artery lesions.
    Yin W, Wang X, Ding Y, Peng H, Liu YL, Wang RG, Yang YL, Xiong JH, Kang SX.
    Indian J Pediatr; 2011 Nov 01; 78(11):1378-82. PubMed ID: 21688043
    [Abstract] [Full Text] [Related]

  • 16. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
    Clin Exp Med; 2022 Nov 01; 22(4):621-628. PubMed ID: 35039938
    [Abstract] [Full Text] [Related]

  • 17. The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease.
    Sun Y, Liu J, Geng Z, Tao Y, Zheng F, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2020 Mar 17; 18(1):23. PubMed ID: 32183825
    [Abstract] [Full Text] [Related]

  • 18. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
    Cardiovasc Ther; 2021 Mar 17; 2021():6660407. PubMed ID: 34239607
    [Abstract] [Full Text] [Related]

  • 19. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J, Liu P, Hu W, Xu Y, Deng J.
    Clin Rheumatol; 2021 Oct 17; 40(10):4191-4197. PubMed ID: 34059986
    [Abstract] [Full Text] [Related]

  • 20. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
    Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.
    Kaohsiung J Med Sci; 2012 Jan 17; 28(1):23-9. PubMed ID: 22226058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.